The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Emerging trends in hepatocellular carcinoma incidence and mortality
Open accessAbstract
The rise in incidence of hepatocellular carcinoma (HCC) in the United States has been well documented. The purpose of this analysis was to examine temporal trends in HCC incidence, mortality, and survival within the U.S. population. The Surveillance, Epidemiology, and End Results data were used to examine incidence and incidence‐based (IB) mortality in HCC from 1973 to 2011. Secular trends in age‐adjusted incidence and IB mortality by sex and cancer stage were characterized using the Joinpoint Regression program. In 1973, HCC incidence was 1.51 cases per 100,000, whereas in 2011, HCC incidence was 6.20 cases per 100,000. Although HCC incidence continues to increase, a slowing of the rate of increase occurs around 2006. In a sensitivity analysis, there was no significant increase in incidence and IB mortality from 2009 to 2011. There was a significant increase in overall median survival from the 1970s to 2000s (2 vs. 8 months; P < 0.001). On multivariable Cox's regression analysis, age, sex, race, tumor grade, stage at diagnosis, lymph/vascular invasion, number of primary tumors, tumor size, and liver transplant were independently associated with mortality. Conclusion: Our results indicate a deceleration in the incidence of HCC around 2006. Since 2009 and for the first time in four decades, there is no increase in IB mortality and incidence rates for HCC in the U.S. population. The nonsignificant increase in incidence and IB mortality in recent years suggest that the peak of the HCC epidemic may be near. A significant survival improvement in HCC was also noted from 1973 to 2010, which seems to be driven by earlier detection of HCC at a curative stage and greater utilization of curative modalities (especially transplant). (H epatology 2015;61:191–199)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Diagnosis and Treatment of Hepatocellular Carcinoma
El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.090 · Cited by 1,137
Hepatocellular carcinoma: Recent trends in the United States
El-Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 972
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
Yuen, M.-F., Tanaka, Y., Fong, D. Y.-T., Fung, J., Wong, D. K.-H., Yuen, J. C.-H., But, D. Y.-K., Chan, A. O.-O., Wong, B. C.-Y., Mizokami, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.023 · Cited by 584
Trends in esophageal adenocarcinoma incidence and mortality
Hur, C., Miller, M., Kong, C. Y., Dowling, E. C., Nattinger, K. J., Dunn, M., & Feuer, E. J. (2013) · Cancer · doi:10.1002/cncr.27834 · Cited by 507
El-Serag, H. B., Mason, A. C., & Key, C. (2001) · Hepatology · doi:10.1053/jhep.2001.21041 · Cited by 353
Chen, J., Yang, H., Iloeje, U. H., You, S., Lu, S., Wang, L., Su, J., Sun, C., Liaw, Y., & Chen, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.042 · Cited by 331
Altekruse, S. F., McGlynn, K. A., Dickie, L. A., & Kleiner, D. E. (2012) · Hepatology · doi:10.1002/hep.24710 · Cited by 262
Artinyan, A., Mailey, B., Sanchez‐Luege, N., Khalili, J., Sun, C., Bhatia, S., Wagman, L. D., Nissen, N., Colquhoun, S. D., & Kim, J. (2010) · Cancer · doi:10.1002/cncr.24817 · Cited by 250
Non-alcoholic Steatohepatitis and Cancer
Bugianesi, E. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.006 · Cited by 245
A Systematic Review: Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma
Mavros, M. N., Mayo, S. C., Hyder, O. N., & Pawlik, T. M. (2012) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.08.001 · Cited by 150
Mathur, A. K., Osborne, N. H., Lynch, R., Ghaferi, A. A., Dimick, J. B., & Sonnenday, C. J. (2010) · Archives of Surgery · doi:10.1001/archsurg.2010.272 · Cited by 146
VALIDITY OF DEATH CERTIFICATES FOR INJURY-RELATED CAUSES OF DEATH
Moyer, L. A., BOYLE, C. A., & Pollock, D. A. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115403 · Cited by 142
Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance
Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Chaiteerakij, R., Enders, F., Therneau, T. M., Orsini, L. S., Kim, W. R., & Roberts, L. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.027 · Cited by 124
Kao, W., Su, C., Chau, G., Lui, W., Wu, C.-W., & Wu, J. (2011) · World Journal of Surgery · doi:10.1007/s00268-010-0928-z · Cited by 93
Racial differences in liver inflammation and fibrosis related to chronic hepatitis C
Crosse, K., Umeadi, O. G., Anania, F. A., Laurin, J. M., Papadimitriou, J., Drachenberg, C., & Howell, C. D. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00162-4 · Cited by 67
Screening for hepatocellular carcinoma
Sherman, M. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.11.006 · Cited by 49
Wong, R. J., & Corley, D. A. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0661-8 · Cited by 45
Screening for hepatocellular carcinoma
Sherman, M. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00180.x · Cited by 39
Revisiting the natural history of chronic hepatitis B: Impact of new concepts on clinical management
Yuen, M. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04938.x · Cited by 38
Screening for hepatocellular carcinoma.
Singal, A. S., & Marrero, J. A. (2008) · PubMed Central · Cited by 26
Cited by
Paik, J. M., Golabi, P., Younossi, Y., Mishra, A., & Younossi, Z. M. (2020) · Hepatology · doi:10.1002/hep.31173 · Cited by 788
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
Perumpail, B. J., Khan, M. A., Yoo, E. R., Cholankeril, G., Kim, D., & Ahmed, A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i47.8263 · Cited by 735
Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis
Rowe, J., Ghouri, Y., & Mian, I. (2017) · Journal of Carcinogenesis · doi:10.4103/jcar.jcar_9_16 · Cited by 719
Global trends and predictions in hepatocellular carcinoma mortality
Bertuccio, P., Turati, F., Carioli, G., Rodriguez, T., La Vecchia, C., Malvezzi, M., & Negri, E. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.011 · Cited by 632
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
Singal, A. G., & El-Serag, H. B. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.014 · Cited by 530
Metadata
- Authors
- Njei, B., Rotman, Y., Ditah, I., & Lim, J. K.
- Venue
- Hepatology
- Published
- 2014-11-24
- Volume
- 61
- Issue
- 1
- Pages
- 191-199
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W1530007295
- Cited by
- 539
- References
- 27
- FWCI
- 21.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.